Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May 2;20(1):20251182.
doi: 10.1515/med-2025-1182. eCollection 2025.

Necroptosis of hippocampal neurons in paclitaxel chemotherapy-induced cognitive impairment mediates microglial activation via TLR4/MyD88 signaling pathway

Affiliations

Necroptosis of hippocampal neurons in paclitaxel chemotherapy-induced cognitive impairment mediates microglial activation via TLR4/MyD88 signaling pathway

Lan-Lan Liu et al. Open Med (Wars). .

Abstract

Background: Paclitaxel (PTX) chemotherapy frequently induces cognitive impairment, which is closely associated with two key pathological processes: necroptosis of hippocampal neurons and microglial polarization. Necroptotic neurons release damage-associated molecular patterns, triggering inflammatory responses. As the primary immune cells in the central nervous system, microglia can exhibit either pro-inflammatory or anti-inflammatory activity depending on their polarization state. However, the relationship between PTX-induced neuronal necroptosis and microglial activation remains unclear.

Methods: In this study, both in vivo and in vitro experiments were conducted. In vivo, an adult male C57BL/6N mouse model of PTX-induced cognitive impairment was established and divided into three groups: Veh (vehicle control), PTX (paclitaxel only), and P + N (paclitaxel with Nec-1 treatment). Necrostatin-1 (Nec-1), a specific inhibitor of RIPK1, was used to inhibit necroptosis. In vitro, HT22 cells were used to prepare necroptosis-conditioned medium, and BV-2 cells were treated with this medium. TAK-242, a TLR4 inhibitor, was used to explore the role of the TLR4/MyD88 signaling pathway. Immunofluorescence staining, western blot, and ELISA were employed to detect relevant markers and cytokines.

Results: The results demonstrated that PTX-induced necroptosis of hippocampal neurons activated microglia. Nec-1 effectively suppressed neuronal necroptosis and reduced M1 polarization of microglia. The TLR4/MyD88 signaling pathway was involved in microglial polarization induced by the necroptotic-conditioned medium of PTX-treated HT22 cells. TAK-242 significantly blocked the regulatory effect of PTX-induced neuronal necroptosis on BV-2 microglial polarization.

Conclusion: This study reveals that hippocampal neuron necroptosis activates microglia through the TLR4/MyD88 signaling pathway in PTX-induced cognitive impairment, promoting M1 polarization and neuroinflammation. Inhibiting necroptosis promotes M2 polarization and neuroprotection. These findings uncover a novel mechanism of PTX-induced cognitive impairment and suggest potential therapeutic targets.

Keywords: DAMPs; TLR4/MyD88 signaling pathway; microglia polarization; necroptosis; paclitaxel.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: The authors state no conflict of interest.

Figures

Figure 1
Figure 1
Workflow chart of PTX-induced cognitive impairment mice model construction and group treatment.
Figure 2
Figure 2
Necroptosis of hippocampal neurons induces microglial polarization toward M1 and inhibits its polarization toward M2. (a) Microphotographs of fluorescent immunohistochemical staining showing labeling of Iba-1 (red). Bar = 50 µm, n = 3 mice/group. (b) Number of microglial cells. Results were expressed as the Mean ± SEM, n = 3 mice/group, ***P < 0.001, ****P < 0.0001. Abbreviation: Veh, vehicle; PTX, paclitaxel; P + N, paclitaxel + necrostatin-1. (c) Microphotographs of fluorescent immunohistochemical staining showing double labeling of iNOS (green) and Iba-1 (red). Bar = 50 µm. (d) Number of microglial cells and iNOS co-labeled cells as a percentage of the number of microglial cells. Results were expressed as the Mean ± SEM, n = 3 mice/group. (e) Microphotographs of fluorescent immunohistochemical staining showing double labeling of Arg-1 (green) and Iba-1 (red). Bar = 50 µm. (f) Number of microglial cells and Arg-1 co-labeled cells as a percentage of the number of microglial cells. Results were expressed as the Mean ± SEM, n = 3 mice/group. (g)–(i) Western blot expression of iNOS and Arg-1 in the hippocampus of mice in different groups. (j) and (k) Effects on the levels of inflammatory molecules TNF-α and IL-1β secreted by M1 microglia in the hippocampus of mice in different groups. All data are shown as the Mean ± SEM, n = 3 for each group. (l) and (m) Effects on the levels of anti-inflammatory molecules IL-4 and IL-10 secreted by M2 microglia in the hippocampus of mice in different groups. All data are shown as the Mean ± SEM, n = 3 for each group.
Figure 3
Figure 3
Necroptosis of hippocampal neurons leads to decreased BDNF release from microglia and activation of TLR4/MyD88 signaling pathway. (a) Microphotographs of fluorescent immunohistochemical staining showing double labeling of BDNF (green) and Iba-1 (red). Bar = 50 µm. (b) Number of microglial cells and BDNF co-labeled cells as a percentage of the number of microglial cells. Results were expressed as the Mean ± SEM, n = 3 mice/group, **P < 0.01, ****P < 0.0001. Abbreviation: Veh, vehicle; PTX, paclitaxel; P + N, paclitaxel + necrostatin-1. (c) Microphotographs of fluorescent immunohistochemical staining showing double labeling of TLR4 (green) and Iba-1 (red). Bar = 50 µm. (d) Number of microglial cells and TLR4 co-labeled cells as a percentage of the number of microglial cells. Results were expressed as the Mean ± SEM, n = 3 mice/group. (e) Microphotographs of fluorescent immunohistochemical staining showing double labeling of MyD88 (green) and Iba-1 (red). Bar = 50 µm. (f) Number of microglial cells and MyD88 co-labeled cells as a percentage of the number of microglial cells. Results were expressed as the Mean ± SEM, n = 3 mice/group. (g)–(j) Western blot expression of BDNF, TLR4, and MyD88 in the hippocampus of mice in different groups. All data are shown as the Mean ± SEM, n = 3 for each group.
Figure 4
Figure 4
Preparation of DAMPs in the conditioned medium for PTX-induced necroptosis of HT22 cells and the conditioned medium for PTX-induced necroptosis of HT22 cells can induce BV-2 cells to polarize toward M1. (a) Preparation of PTX-induced necroptosis-conditioned culture medium of HT22 cells. (b) and (c) Effects of necroptosis-conditioned culture medium of different groups of HT22 cells on iNOS expression in BV-2 cells. (d) Effects of necroptosis-conditioned culture medium of different groups of HT22 cells on TNF-α release of BV-2 cells. (e) Effects of necroptosis-conditioned culture medium of different groups of HT22 cells on IL-1β release of BV-2 cells. All data are shown as the Mean ± SEM, n = 3 mice/group, **P < 0.01, ***P < 0.001, ****P < 0.0001. Abbreviation: Veh, vehicle; PTX, paclitaxel; P + N, paclitaxel + necrostatin-1.
Figure 5
Figure 5
Polarization of microglia induced by conditioned medium of HT22 cells necroptosis is mediated by TLR4/MyD88 signaling pathway. (a) and (b) Effect of TAK-242 on MyD88 protein expression in BV-2 cells caused by necroptosis of HT22 cells in conditioned culture medium. All data are shown as the Mean ± SEM, n = 3, *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. Abbreviation: Veh, vehicle; PTX, paclitaxel; P + N, paclitaxel + necrostatin-1. (c) Morphological changes of BV-2 cells in different treatment groups. Bar = 100 µm. (d)–(f) Western blot expression of iNOS and Arg-1 in the BV-2 cells in different groups. (g)–(h) Effects on the levels of inflammatory molecules TNF-α and IL-1β secreted by M1 microglia in the BV-2 cells in different groups. (i) and (j) Effects on the levels of anti-inflammatory molecules IL-4 and IL-10 secreted by M2 microglia in the BV-2 cells in different groups. All data are shown as the Mean ± SEM, n = 3 for each group.

Similar articles

References

    1. Hermelink K. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer. 2011 Mar;117(5):1103–4. - PubMed
    1. Ahire C, Nyul-Toth A, DelFavero J, Gulej R, Faakye JA, Tarantini S, et al. Accelerated cerebromicrovascular senescence contributes to cognitive decline in a mouse model of paclitaxel (Taxol)-induced chemobrain. Aging Cell. 2023 Jul;22(7):e13832. - PMC - PubMed
    1. Nguyen LD, Fischer TT, Ehrlich BE. Pharmacological rescue of cognitive function in a mouse model of chemobrain. Mol Neurodegener. 2021 Jun;16(1):41. 10.1186/s13024-021-00463-2 - DOI - PMC - PubMed
    1. Vandenabeele P, Galluzzi L, Vanden Berghe T, Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol. 2010 Oct;11(10):700–14. - PubMed
    1. Moriwaki K, Bertin J, Gough PJ, Orlowski GM, Chan FK. Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death. Cell Death Dis. 2015 Feb;6(2):e1636. - PMC - PubMed

LinkOut - more resources